Help
RSS
API
Feed
Maltego
Contact
Domain > ir.tcbiopharm.com
×
More information on this domain is in
AlienVault OTX
Is this malicious?
Yes
No
DNS Resolutions
Date
IP Address
2021-10-20
3.221.176.71
(
ClassC
)
2022-02-03
3.225.74.242
(
ClassC
)
2023-06-17
54.204.13.102
(
ClassC
)
2026-01-04
52.53.61.56
(
ClassC
)
Port 443
HTTP/1.1 200 OKDate: Sun, 04 Jan 2026 11:39:37 GMTServer: ApacheX-Frame-Options: SAMEORIGINStrict-Transport-Security: max-age31536000;X-XSS-Protection: 1; modeblockX-Content-Type-Options: nosniffFeature-Policy: microphone none; camera none; geolocation none; screen-wake-lock none;Referrer-Policy: strict-origin-when-cross-originContent-Security-Policy: default-src *.gstatic.com ir.stockpr.com ir.tcbiopharm.com d1io3yog0oux5.cloudfront.net *.equisolve-dev.com *.equisolve.net; script-src *.quotemedia.com *.google.com *.google-analytics.com *.gstatic.com browser-update.org cdn.sajari.com cdn.sajari.net jsonapi.sajari.net *.hcaptcha.com hcaptcha.com ir.stockpr.com *.usersnap.com *.googletagmanager.com ir.tcbiopharm.com d1io3yog0oux5.cloudfront.net *.equisolve-dev.com *.equisolve.net unsafe-inline; connect-src *.quotemedia.com *.google.com *.google-analytics.com *.gstatic.com browser-update.org cdn.sajari.com cdn.sajari.net jsonapi.sajari.net *.hcaptcha.com hcaptcha.com ir.stockpr.com *.usersnap.com *.googletagmanager.com ir.tcbiopharm.com d1io3yog0oux5.cloudfront.net *.equisolve-dev.com *.equisolve.net unsafe-inline; style-src fonts.googleapis.com *.gstatic.com *.hcaptcha.com hcaptcha.com ir.stockpr.com ir.tcbiopharm.com d1io3yog0oux5.cloudfront.net *.equisolve-dev.com *.equisolve.net unsafe-inline; font-src cdnjs.cloudflare.com/ajax/libs/font-awesome/ fonts.googleapis.com *.gstatic.com ir.stockpr.com ir.tcbiopharm.com d1io3yog0oux5.cloudfront.net *.equisolve-dev.com *.equisolve.net; img-src c212.net pixel.mathtag.com mma.prnewswire.com prnewswire.com ir.stockpr.com ir.tcbiopharm.com d1io3yog0oux5.cloudfront.net *.equisolve-dev.com *.equisolve.net; frame-src *.google.com youtube.com youtube-nocookie.com vimeo.com *.hcaptcha.com hcaptcha.com ir.stockpr.com ir.tcbiopharm.com d1io3yog0oux5.cloudfront.net *.equisolve-dev.com *.equisolve.net; object-src *.gstatic.com ir.stockpr.com ir.tcbiopharm.com d1io3yog0oux5.cloudfront.net *.equisolve-dev.com *.equisolve.net;Vary: Accept-EncodingTransfer-Encoding: chunkedContent-Type: text/html; charsetUTF-8 !DOCTYPE html>html langen> head> meta http-equivx-ua-compatible contentieedge> meta charsetutf-8> link relalternate typeapplication/rss+xml titleTC BioPharm Limited - Recent News hrefhttps://ir.tcbiopharm.com/news/press-releases/rss /> title>TC BioPharm Limited (TCBP)/title> link relcanonical hrefhttps://ir.tcbiopharm.com>meta propertyog:url contenthttps://ir.tcbiopharm.com>meta propertyog:site_name contentTC BioPharm Limited>meta propertyog:title contentInvestors>meta propertyog:type contentwebsite>meta propertyog:image contenthttps://d1io3yog0oux5.cloudfront.net/_6df6912d78757007d7d89ae672512318/tcbiopharm/db/873/7009/social_image_resized.jpg>meta nametwitter:card contentsummary_large_image>meta propertyog:description contentWe are developing safer, less expensive CAR-T products which can target more cancers and save more lives. We do this using our integrated model which drives the development of our products through preclinical testing to the clinic. Our mission is…>meta namedescription contentWe are developing safer, less expensive CAR-T products which can target more cancers and save more lives. We do this using our integrated model which drives the development of our products through preclinical testing to the clinic. Our mission is…>script typeapplication/ld+json> {@context:http:\/\/schema.org,@type:Corporation,name:TC BioPharm Limited,address:{@type:PostalAddress,streetAddress:Maxim 1 2 Parklands Way,addressLocality:Holytown, Motherwell,postalCode:ML1 4WR,addressCountry:United Kingdom},legalName:TC BioPharm Limited,description:We are developing safer, less expensive CAR-T products which can target more cancers and save more lives. We do this using our integrated model which drives the development of our products through preclinical testing to the clinic. Our mission is to develop and commercialize innovative cell-based products and to treat disease, improve patient health and Quality of Life.\r\nTC BioPharm (TCBP) is a publicly traded, clinical-stage cell therapy company developing advanced allogeneic CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease.,tickerSymbol:: TCBP,url:https:\/\/ir.tcbiopharm.com,logo:https:\/\/d1io3yog0oux5.cloudfront.net\/_6df6912d78757007d7d89ae672512318\/tcbiopharm\/logo.png,image:https:\/\/d1io3yog0oux5.cloudfront.net\/_6df6912d78757007d7d89ae672512318\/tcbiopharm\/db\/873\/7009\/social_image_resized.jpg,sameAs:}/script> meta nameviewport contentinitial-scale1.0, widthdevice-width> link relpreconnect hrefhttps://d1io3yog0oux5.cloudfront.net> link relpreconnect hrefhttps://qmod.quotemedia.com> link hrefhttps://d1io3yog0oux5.cloudfront.net/_6df6912d78757007d7d89ae672512318/tcbiopharm/files/theme/css/ir.stockpr.css relstylesheet typetext/css mediascreen /> link relstylesheet hrefhttps://d1io3yog0oux5.cloudfront.net/_6df6912d78757007d7d89ae672512318/tcbiopharm/files/theme/css/style.css> link relshortcut icon hrefhttps://d1io3yog0oux5.cloudfront.net/_6df6912d78757007d7d89ae672512318/tcbiopharm/files/theme/images/favicons/favicon.ico> link relapple-touch-icon sizes180x180 hrefhttps://d1io3yog0oux5.cloudfront.net/_6df6912d78757007d7d89ae672512318/tcbiopharm/files/theme/images/favicons/apple-touch-icon.png> link relicon typeimage/png hrefhttps://d1io3yog0oux5.cloudfront.net/_6df6912d78757007d7d89ae672512318/tcbiopharm/files/theme/images/favicons/favicon-32x32.png sizes32x32> link relicon typeimage/png hrefhttps://d1io3yog0oux5.cloudfront.net/_6df6912d78757007d7d89ae672512318/tcbiopharm/files/theme/images/favicons/favicon-16x16.png sizes16x16> link relmanifest hrefhttps://d1io3yog0oux5.cloudfront.net/_6df6912d78757007d7d89ae672512318/tcbiopharm/files/theme/images/favicons/manifest.json> link relmask-icon hrefhttps://d1io3yog0oux5.cloudfront.net/_6df6912d78757007d7d89ae672512318/tcbiopharm/files/theme/images/favicons/safari-pinned-tab.svg> meta nametheme-color content#ffffff> !-- Global site tag (gtag.js) - Google Analytics -->script async srchttps://www.googletagmanager.com/gtag/js?idG-DR88XHTFZK>/script>script>window.dataLayer window.dataLayer || ;function gtag(){dataLayer.push(arguments);}gtag(js, new Date());gtag(config, G-DR88XHTFZK);/script> script idanalyticsOptions typeapplication/json>{ domain: ir.tcbiopharm.com, gaId: G-DR88XHTFZK}/script>script idgoogle-analytics srchttps://d1io3yog0oux5.cloudfront.net/_6df6912d78757007d7d89ae672512318/tcbiopharm/files/theme/js/aside/google-analytics/_js/all.js >/script> /head>body classpg-107607 page-type-ir-overview pg-overview-overview ir > div classgeneral-wrapper> nav idheader classaffixed aria-labelMain> div idskipLinks> a href#mainContent>Skip to main content/a> a href#footer>Skip to footer/a> /div> section classzero-nav d-sm-block aria-labelStock Information> div classcontainer-fluid> div classrow justify-content-end> div classcol-12 col-md-8 col-lg-7 col-xl-6> div classrow justify-content-end> div classcol-auto> span classbtn--back-to-site> a hrefhttps://TCBiopharm.com>TCBiopharm.com/a> /span> /div> /div> /div> /div> /div>/section> div classcontainer-fluid> h1 classlogo> a href/> img srchttps://d1io3yog0oux5.cloudfront.net/_6df6912d78757007d7d89ae672512318/tcbiopharm/files/theme/images/logo-header.svg width164 height37 altTC BioPharm Limited> /a> /h1> a rolebutton classmobile-nav-trigger idshowRight aria-labelExpand main navigation aria-controlsmobile-nav> div classmeat>/div> div classmeat>/div> div classmeat>/div> /a> div classcbp-spmenu cbp-spmenu-vertical cbp-spmenu-right main-nav idmobile-nav> ul classmain-menu> li classsr-only>a href/>Investors/a>/li> li classactive active-landing data-submenu-idsubmenu-overview> a href/ target_self >Overview/a> /li> li classhas-children data-submenu-idsubmenu-news> a href/news target_self >News/a> ul idsubmenu-news> li class> a href/news target_self >Overview/a> /li> li class> a href/news/press-releases target_self >Press Releases/a> /li> li class> a href/news/media-coverage target_self >Media Coverage/a> /li> li class> a href/news/email-alerts target_self >Email Alerts/a> /li> /ul> /li> li classhas-children data-submenu-idsubmenu-events-presentations> a href/events-presentations target_self >Events & Presentations/a> ul idsubmenu-events-presentations> li class> a href/events-presentations target_self >Overview/a> /li> li class> a href/events-presentations/events target_self >Events/a> /li> li class> a href/events-presentations/presentations target_self >Presentations/a> /li> /ul> /li> li classhas-children data-submenu-idsubmenu-company-information> a href/company-information target_self >Company Info/a> ul idsubmenu-company-information> li class> a href/company-information target_self >Overview/a> /li> li class> a href/company-information/management-team target_self >Management Team/a> /li> li class> a href/company-information/contacts target_self >Contacts/a> /li> li class> a href/company-information/faq target_self >FAQ/a> /li> /ul> /li> li classhas-children data-submenu-idsubmenu-financial-information> a href/financial-information target_self >Financial Info/a> ul idsubmenu-financial-information> li class> a href/financial-information target_self >Overview/a> /li> li class> a href/financial-information/financial-results target_self >Financial Results/a> /li> li class> a href/financial-information/income-statement target_self >Income Statement/a> /li> li class> a href/financial-information/balance-sheet target_self >Balance Sheet/a> /li> li class> a href/financial-information/cash-flow target_self >Cash Flow/a> /li> /ul> /li> li classhas-children data-submenu-idsubmenu-stock-data> a href/stock-data target_self >Stock Data/a> ul idsubmenu-stock-data> li class> a href/stock-data/quote target_self >Quote/a> /li> li class> a href/stock-data/charts target_self >Charts/a> /li> li class> a href/stock-data/historical-data target_self >Historical Data/a> /li> /ul> /li> li classhas-children data-submenu-idsubmenu-sec-filings> a href/sec-filings target_self >SEC Filings/a> ul idsubmenu-sec-filings> li class> a href/sec-filings target_self >Overview/a> /li> li class> a href/sec-filings/all-sec-filings target_self >All SEC Filings/a> /li> li class> a href/sec-filings/annual-reports target_self >Annual Reports/a> /li> li class> a href/sec-filings/quarterly-reports target_self >Quarterly Reports/a> /li> li class> a href/sec-filings/section-16-filings target_self >Section 16 Filings/a> /li> li class> a hrefhttps://ir.tcbiopharm.com/sec-filings/all-sec-filings/content/0001641172-25-008755/0001641172-25-008755.pdf target_blank relnoopener>General Meeting/a> /li> /ul> /li> li classhas-children data-submenu-idsubmenu-corporate-governance> a href/corporate-governance target_self >Governance/a> ul idsubmenu-corporate-governance> li class> a href/corporate-governance target_self >Overview/a> /li> li class> a href/corporate-governance/board-of-directors target_self >Board of Directors/a> /li> li class> a href/corporate-governance/board-committees target_self >Board Committees/a> /li> li class> a href/corporate-governance/governance-documents target_self >Governance Documents/a> /li> /ul> /li> /ul> /div> /div>/nav> div classpage-banner overlay stylebackground: url(https://d1io3yog0oux5.cloudfront.net/_6df6912d78757007d7d89ae672512318/tcbiopharm/files/theme/images/pagebanner-default.jpg);background-position: 50% 50%;background-repeat: no-repeat;background-size: cover;background-color: #333;> div classcontainer> div classvertical-align> div classwrapper text> div classrow justify-content-center> div classcol-lg-10> h1>Notice of the 2025 Annual General Meeting/h1> /div> div classcol-lg-8> div classdescription> br>p styletext-align: center;>a hrefhttps://d1io3yog0oux5.cloudfront.net/_0231a78830f1302b2d4f497c9b2ee938/tcbiopharm/files/pages/tcbiopharm/db/883/content/TC_BIOPHARM_%28HOLDINGS%29_PLC_-_AGM_notice.pdf target_blank relnoopener classblock-link btn stylecolor: #fff;>Notice of the 2025 Annual General Meeting/a>/p> /div> /div> /div> /div> /div> /div>/div> main idmainContent> section classmodule module-latest-news > div classcontainer> div classrow> div classcol-md-6> h2>Latest News/h2> /div> div classcol-md-6 my-auto> a hrefhttps://ir.tcbiopharm.com/news/press-releases classblock-link btn>View All News/a> /div> /div> div classfeatured-news-listing> div classrow> div classcol-md-12> div classcontent-box background overlay dark stylebackground: url(https://d1io3yog0oux5.cloudfront.net/_6df6912d78757007d7d89ae672512318/tcbiopharm/db/919/7336/image.jpg);background-position: 50% 50%;background-repeat: no-repeat;background-size: cover;background-color: #333;> div classtext> div classheader> time classdate datetime2025-06-11T08:30:00>June 11, 2025 • 8:30am EDT/time> /div>!--end header--> p>TC BioPharm Announces Complete Response in Minimal Residual Disease (MRD) Patient/p> div classinline-block-links> a hrefhttps://ir.tcbiopharm.com/news/press-releases/detail/125/tc-biopharm-announces-complete-response-in-minimal-residual classblock-link btn>View Press Release/a> /div> /div> /div> /div>!--end col--> /div>!--end row--> /div>!--end featured--> div classnews-listing> div classrow> div classcol-lg-4> div classcontent-box> div classtext> article classmedia> p classdate> time datetime2025-04-09T09:00:00> April 9, 2025 /time> /p> h3 classmedia-heading data-mhmedia-heading>TCBP Announces Grant of European Patent for Targeting of Microbial, Oncological, and Viral Indications using Modified Gamma Delta T Cells /h3> /article> a hrefhttps://ir.tcbiopharm.com/news/press-releases/detail/124/tcbp-announces-grant-of-european-patent-for-targeting-of aria-hiddentrue classblock-link btn>View Press Release/a> /div> /div> /div> div classcol-lg-4> div classcontent-box> div classtext> article classmedia> p classdate> time datetime2025-03-21T10:45:00> March 21, 2025 /time> /p> h3 classmedia-heading data-mhmedia-heading>TCBP Announces Transition from Nasdaq to OTC Markets /h3> /article> a hrefhttps://ir.tcbiopharm.com/news/press-releases/detail/123/tcbp-announces-transition-from-nasdaq-to-otc-markets aria-hiddentrue classblock-link btn>View Press Release/a> /div> /div> /div> div classcol-lg-4> div classcontent-box> div classtext> article classmedia> p classdate> time datetime2025-03-18T08:03:00> March 18, 2025 /time> /p> h3 classmedia-heading data-mhmedia-heading>TCBP Announces Outsourcing Initiatives, Reducing Burn Rate and Overhead /h3> /article> a hrefhttps://ir.tcbiopharm.com/news/press-releases/detail/122/tcbp-announces-outsourcing-initiatives-reducing-burn-rate aria-hiddentrue classblock-link btn>View Press Release/a> /div> /div> /div> /div> /div> /div>/section>div classmodule module-presentation-event primary-color-bg > div classcontainer> div classpresentation-events row> article classitem presentation col-lg col-md-12> div classcontent-box> div classtext> div classheader data-mhpresentation-event-header> h2 classheading--h3>Latest Presentation/h2> time datetime2025-02-27T00:00:00 classdate> February 27, 2025 /time> /div>!-- /header--> p> a hrefhttps://d1io3yog0oux5.cloudfront.net/_6df6912d78757007d7d89ae672512318/tcbiopharm/db/856/7534/pdf/TCBP+-+Corporate+Deck+-+Q1+2025.pdf target_blank relnoopener> Investor Presentation /a> /p> div classitem-links inline-block-links> a hrefhttps://d1io3yog0oux5.cloudfront.net/_6df6912d78757007d7d89ae672512318/tcbiopharm/db/856/7534/pdf/TCBP+-+Corporate+Deck+-+Q1+2025.pdf target_blank relnoopener classblock-link btn>View Presentation/a> a href/events-presentations/presentations classblock-link btn>All Presentations/a> /div> /div>!-- /text--> /div> /article>!-- /item--> /div> /div>/div>div idfinancial-results classmodule module-overview-financial-results no-bg > div classcontainer> div classrow> div classcol-md-12> div classheader>h2>Latest Financial Results/h2>/div> /div> /div> div classrow> div classcol-md-6 fin-col results> h3>FY 2024/h3> p classdate>Fiscal Year Ended December 31, 2024/p> div classtext> div class > div> div classresult-line> div classrow justify-content-between> div classcol> a href/sec-filings/all-sec-filings/content/0001641172-25-009445/form20-f.htm title20-F Filing Viewer classfancybox fancybox.iframe relnoopener>20-F span classsr-only>Filing/span>/a> /div> div classcol> a href/sec-filings/all-sec-filings/content/0001641172-25-009445/0001641172-25-009445.pdf title20-F classlink target_blank relnoopener>span classeqicon-PDF>/span>PDF/a> a href/sec-filings/all-sec-filings/content/0001641172-25-009445/form20-f.htm title20-F Filing Viewer relnoopener classlink fancybox fancybox.iframe>span classeqicon-HTML>/span>HTML/a> /div> /div>/div>div classresult-line> div classrow justify-content-between> div classcol> a href/sec-filings/all-sec-filings/xbrl_doc_only/532 titleXBRL Viewer target_blank relnoopener classfancybox fancybox.iframe>XBRL/a> /div> div classcol> a href/sec-filings/all-sec-filings/content/0001641172-25-009445/0001641172-25-009445-xbrl.zip titleDownload Raw XBRL Files classlink target_blank relnoopener>span classeqicon-ZIP>/span>ZIP/a> a hrefhttps://content.equisolve.net/sec/0001641172-25-009445/Financial_Report.xlsx titleXBRL Spreadsheet classlink target_blank relnoopener>span classeqicon-PDF>/span>XLS/a> a href/sec-filings/all-sec-filings/xbrl_doc_only/532 titleXBRL Viewer classlink fancybox fancybox.iframe target_blank relnoopener>span classeqicon-HTML>/span>HTML/a> /div> /div>/div> /div> /div>/div> /div> div classcol-md-6> img srchttps://d1io3yog0oux5.cloudfront.net/_6df6912d78757007d7d89ae672512318/tcbiopharm/db/919/7347/image.jpg alt> /div> /div> div classar-row> section> h2>Latest Annual Filing/h2> p>For Fiscal Year Ending December 31, 2024/p> /section> section classreport-links> h3 classsr-only>Report Links/h3> nav classinline-btns right aria-labelledbydocument-navigation> h4 iddocument-navigation classsr-only>Annual Report Document Links/h4> a href/sec-filings/all-sec-filings/content/0001641172-25-009445/0001641172-25-009445.pdf classblock-link btn target_blank relnoopener>View 20-F/a> /nav> /section> /div> /div>/div>div classsubscribe subscribe-module dark> div classcontainer> div classrow justify-content-between> div classcol-lg-3 my-auto> h2>Email Alerts/h2> /div> div classcol-lg-7 my-auto> div classtext> p>Sign up today and receive company updates straight to your inbox./p> /div> /div> div classcol-lg-2 my-auto> a href/news/email-alerts classblock-link btn>Sign up today/a> /div> /div> /div>/div>section classhome-ir-module module no-padding neutral-bg > div classcontainer> div classstock-info quote-box qtool data-qmod-tooldetailedquotetab data-qmod-params{"lang":"en","showLogo":false,"lowHigh":false,"symbol":"TCBP"}> span classloader>/span> script typetext/template> div classqmod-ui-tool> div classtext> div classrow> div classcol-md-4 col-lg-2 symbol> div classstock-box same-height> p classvalue-title>Market/Symbol/p> span classvalue heading--h4> OTCID: TCBP /span> /div> /div> div classcol-md-4 col-lg-2 price> div classstock-box price same-height> p classvalue-title>{tplLang.last| toLang tLang}/p> span classvalue heading--h4> ${data.pricedata.last | asQHLast tLang } /span> /div> /div> div classcol col-md-4 col-lg-2 change> div classstock-box change same-height> p classvalue-title>Change/p> span classvalue heading--h4> span rv-qmodchangedata.pricedata.change classqmod-change> span classnumber>{data.pricedata.change | asQHLast tLang }/span> span classpercent> ({data.pricedata.changepercent | numeraljs 0.00 0.00 | postFix %})/span> /span> /span> /div> /div> div classcol-md-4 col-lg-2> div classstock-box volume same-height> p classvalue-title>{tplLang.volume| toLang tLang}/p> span classvalue heading--h4>{data.pricedata.sharevolume | numeraljs 0.00a} /span> /div> /div> div classcol-md-4 col-lg-2 rv-ifdata.pricedata.low> div classstock-box day-range same-height> p classvalue-title>Day Range/p> span classvalue heading--h4> {data.pricedata.low | asQHLast tLang} - {data.pricedata.high | asQHLast tLang} /span> /div> !-- .stock-box --> /div> !-- .stock-section --> div classcol-md-4 col-lg-2> div classstock-box week-range same-height> p classvalue-title>Year Range/p> span classvalue heading--h4> {data.fundamental.week52low.content | asQHLast tLang} - {data.fundamental.week52high.content | asQHLast tLang} /span> /div> !-- .stock-box --> /div> !-- .stock-section --> /div>!--end row--> /div>!--end text--> /div>/script>/div>!--end stock-info--> /div> !--end container-->/section>section classmodule row-ir-company-overview > div classcontainer> div classrow justify-content-center align-items-center flex-row-reverse> div classcol-lg-6> figure classmodule-image> img srchttps://d1io3yog0oux5.cloudfront.net/_6df6912d78757007d7d89ae672512318/tcbiopharm/db/919/7359/image.jpg alt /> /figure> /div> div classcol-lg-6> div classmodule-content> div classtext-area> div classtext > h2>Company Overview/h2> p>We are developing safer, less expensive CAR-T products which can target more cancers and save more lives. We do this using our integrated model which drives the development of our products through preclinical testing to the clinic. Our mission is to develop and commercialize innovative cell-based products and to treat disease, improve patient health and Quality of Life./p>p>TC BioPharm (TCBP) is a publicly traded, clinical-stage cell therapy company developing advanced allogeneic CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease./p>div classinline-btn> a href/company-information/management-team classblock-link btn>View Management Team/a> a href/corporate-governance/board-of-directors classblock-link btn>View Board of Directors/a> /div> /div> /div> /div> /div> /div> /div>/section>section classcontact-info module primary-color-bg > div classcontainer> div classtext> h2>IR Contacts/h2> div classrow> div classcol-lg contact-col data-mhcontact-col> div classcontent-box> div classtext> h3>Company/h3> p> TC BioPharm Limitedbr> Maxim 1br> 2 Parklands Waybr> Holytown, Motherwell ML1 4WR br>United Kingdom br> T: +44 (0) 141 433 7557 br>a hrefmailto:info@tcbiopharm.com >info@tcbiopharm.com /a> /p> /div> /div> /div> div classcol-lg contact-col data-mhcontact-col> div classcontent-box> div classtext> h3>Investor Relations/h3> p> a hrefmailto:IR@tcbiopharm.com>IR@tcbiopharm.com/a>br> /p> /div> /div> /div> div classcol-lg contact-col data-mhcontact-col> div classcontent-box> div classtext> h3>Transfer Agent/h3> p> Computershare Investor Services PLCbr> /p> /div> /div> /div> /div> /div> /div>/section> /main> div classmodule-quick-links> ul> li> a href/news/email-alerts classemail>Email Alerts/a> /li> li>a href/company-information/contacts classcontacts>Contacts/a>/li> li>a hrefhttps://ir.tcbiopharm.com/news/press-releases/rss classrss target_blank relnoopener>RSS News Feed/a>/li> /ul>/div>footer idfooter classhas-qmod > div classfooter-main> div classcontainer> div classrow justify-content-between align-content-center> div classcol-md-6> div classsocial-links> ul> li classd-inline mr-4> a hrefhttps://www.facebook.com/tcbiopharm/ target_blank relnoopener> img srchttps://d1io3yog0oux5.cloudfront.net/_6df6912d78757007d7d89ae672512318/tcbiopharm/db/875/7452/icon/round+facebook.svg altVisit us on Facebook /> /a> /li> li classd-inline mr-4> a hrefhttps://twitter.com/TCBioPharm target_blank relnoopener> img srchttps://d1io3yog0oux5.cloudfront.net/_6df6912d78757007d7d89ae672512318/tcbiopharm/db/875/7453/icon/round+twitter.svg altVisit us on Twitter /> /a> /li> li classd-inline mr-4> a hrefhttps://www.linkedin.com/company/tc-biopharm-limited target_blank relnoopener> img srchttps://d1io3yog0oux5.cloudfront.net/_6df6912d78757007d7d89ae672512318/tcbiopharm/db/875/7454/icon/round+linkedin.svg altVisit us on LinkedIn /> /a> /li> /ul> /div> /div> div classcol-md-6> div classcopyright> ©time datetime2025>2025/time> a href/>TC BioPharm Limited/a>. All Rights Reserved. /div> div classfooter-links> a href/privacy-policy>Privacy Policy/a>a href/disclaimer>Disclaimer/a>a href/sitemap>Sitemap/a> /div> /div> /div> /div> /div> div classqmod-attribution> div classcontainer> div classq-mod-attribution disclaimer> div classrow justify-content-center> div classcol-md-10 center> p> Market Data copyright © 2026 a hrefhttp://www.quotemedia.com target_blank relnofollow noopener>QuoteMedia/a>. Data delayed 15 minutes unless otherwise indicated (view a hrefhttp://www.quotemedia.com/legal/tos/#times target_blank relnofollow noopener >delay times/a> for all exchanges). span classqmf-rt>RT/span>Real-Time, span classqmf-non-rt>EOD/span>End of Day, span classqmf-non-rt>PD/span>Previous Day. Market Data powered by a hrefhttp://www.quotemedia.com target_blank relnofollow noopener >QuoteMedia/a>. a hrefhttp://www.quotemedia.com/legal/tos/ target_blank relnofollow noopener >Terms of Use/a>. /p> /div> /div> /div> /div>/div>/footer>div idcookie-consent-banner> div classcontainer> div classcontent-box> div classtext> p>This website stores cookies on your computer. These cookies, which also could include third party cookies, are used (among other purposes) to improve the website and provide more personalized services to you. To find out more about how we use cookies and how to change your settings, see our a hrefhttps://TCBiopharm.com/privacy>Privacy Policy/a>./p> a classblock-link btn>I Accept/a> /div> /div> /div>/div>script idcompanyVars typeapplication/json>{ asset_url: https:\/\/d1io3yog0oux5.cloudfront.net\/_6df6912d78757007d7d89ae672512318\/tcbiopharm, website_base_url: https:\/\/ir.tcbiopharm.com, ir_base_url: , hCaptchaSiteKey: 778a5748-d323-4b73-a06c-9625642de8bc, isQmod: true}/script>script srchttps://d1io3yog0oux5.cloudfront.net/_6df6912d78757007d7d89ae672512318/tcbiopharm/files/theme/js/_js/all.js>/script>script idqmod srchttps://qmod.quotemedia.com/js/qmodLoader.js data-qmod-wmid93303 data-qmod-envapp data-qmod-versionv1.34.2 defer>/script>script srchttps://d1io3yog0oux5.cloudfront.net/_6df6912d78757007d7d89ae672512318/tcbiopharm/files/theme/js/aside/_js/browser-check.min.js async>/script> /div>!-- //general-wrapper -->/body>
View on OTX
|
View on ThreatMiner
Please enable JavaScript to view the
comments powered by Disqus.
Data with thanks to
AlienVault OTX
,
VirusTotal
,
Malwr
and
others
. [
Sitemap
]